Last week, Golden Minerals reported that NYSE American notified the company of plans to delist its stock, and said it expected shares would begin trading on the OTC Pink Market Dec. 16. In November, ...

Checkpoint Therapeutics said the Food and Drug Administration approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma, the company's first approval. Checkpoint said in July ...

CubeSmart increased its quarterly dividend to 52 cents a share, from 51 cents. The company said its board of trustees approved the boost, which is the 15th consecutive annual increase in its dividend.